Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 352,134 | 337,685 | 318,028 | 313,964 | 307,435 |
| Cost of Goods | 214,147 | 207,308 | 200,265 | 190,065 | 186,479 |
| Gross Profit | 137,987 | 130,377 | 117,763 | 123,899 | 120,956 |
| Operating Expenses | 68,826 | 67,199 | 65,926 | 60,333 | 64,710 |
| Operating Income | 69,308 | 63,486 | 52,102 | 63,631 | 56,725 |
| Interest Expense | 5,202 | 5,199 | 10,563 | 4,645 | 4,899 |
| Other Income | 1,790 | 1,952 | 3,108 | 1,456 | 1,235 |
| Pre-tax Income | 65,896 | 60,239 | 44,647 | 60,442 | 53,061 |
| Income Tax | 17,088 | 16,183 | 9,458 | 16,808 | 15,101 |
| Net Income Continuous | 48,808 | 44,056 | 35,660 | 43,536 | 37,841 |
| Net Income Discontinuous | N/A | N/A | -2,038 | -759 | 115 |
| Minority Interests | -258 | -83 | N/A | N/A | N/A |
| Net Income | $49,066 | $44,139 | $33,152 | $42,777 | $37,956 |
| EPS Basic Total Ops | 0.73 | 0.65 | 0.49 | 0.64 | 0.57 |
| EPS Basic Continuous Ops | 0.72 | 0.65 | 0.52 | 0.65 | 0.57 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.03 | -0.01 | 0.00 |
| EPS Diluted Total Ops | 0.70 | 0.63 | 0.48 | 0.62 | 0.55 |
| EPS Diluted Continuous Ops | 0.69 | 0.62 | 0.51 | 0.63 | 0.55 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.03 | -0.01 | 0.00 |
| EBITDA(a) | $92,343 | $85,833 | $75,408 | $85,591 | $77,957 |